Studies toward evaluating Gcn2 as a drug target

Summary

Studies toward evaluating Gcn2 as a drug target is a doctoral thesis^[1].

Key Facts

• Studies toward evaluating Gcn2 as a drug target authored Hayley Prescott^[2].
• Studies toward evaluating Gcn2 as a drug target's instance of is recorded as doctoral thesis^[3].
• Studies toward evaluating Gcn2 as a drug target was published by Massey Research Online^[4].
• Studies toward evaluating Gcn2 as a drug target's country of origin is recorded as New Zealand^[5].
• Studies toward evaluating Gcn2 as a drug target was published on 2020^[6].
• Studies toward evaluating Gcn2 as a drug target's main subject is enzymology^[7].
• Studies toward evaluating Gcn2 as a drug target's main subject is therapeutic use^[8].
• Studies toward evaluating Gcn2 as a drug target's main subject is protein kinase^[9].
• Studies toward evaluating Gcn2 as a drug target's title is recorded as Studies toward evaluating Gcn2 as a drug target^[10].
• Studies toward evaluating Gcn2 as a drug target's copyright holder is recorded as Hayley Prescott^[11].
• Studies toward evaluating Gcn2 as a drug target's thesis submitted to is recorded as Massey University^[12].
• Studies toward evaluating Gcn2 as a drug target's on focus list of Wikimedia project is recorded as NZThesisProject^[13].
• Studies toward evaluating Gcn2 as a drug target's copyright status is recorded as copyrighted^[14].
• Studies toward evaluating Gcn2 as a drug target's thesis committee member is recorded as Evelyn Sattlegger^[15].
• Studies toward evaluating Gcn2 as a drug target's thesis committee member is recorded as Martin Dickens^[16].
• Studies toward evaluating Gcn2 as a drug target's thesis submitted for degree is recorded as Doctor of Philosophy^[17].

Body

Designation and Status

Studies toward evaluating Gcn2 as a drug target's instance of is recorded as doctoral thesis^[3].